Manufacturer of Controlled Substances; Notice of Application, 43814-43815 [E6-12475]
Download as PDF
<![CDATA[
43814
Federal Register / Vol. 71, No. 148 / Wednesday, August 2, 2006 / Notices
controlled substances listed in
Schedules II:
Drug
Schedule
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone intermediate (9254) ...
II
II
II
The company plans to manufacture
the listed controlled substance in bulk
for sale to its customer.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12455 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Representative/ODL, 2401
Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no
later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12457 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 19,
2006, Orasure Technologies, Inc.,
Lehigh University, Seeley G. MuddBuilding 6, Bethlehem, Pennsylvania
18015, made application by renewal,
and by letter, to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedule I and II:
DEPARTMENT OF JUSTICE
Drug
wwhite on PROD1PC61 with NOTICES
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) Title
21 of the Code of Federal Regulations
(CFR), this is notice that on June 27,
2006, Noramco Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made
application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
basic drug code (1724)
methylphenidate.
The company plans to bulk
manufacture methylphenidate for a
customer to use in the production of a
controlled substance product.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
VerDate Aug<31>2005
16:40 Aug 01, 2006
Jkt 208001
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12459 Filed 8–1–06; 8:45 am]
Manufacturer of Controlled
Substances; Notice of Application
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR § 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 2, 2006.
Schedule
Lysergic acid diethylamide (LSD)
(7315).
4–Methoxyamphetamine (7411) ...
Normorphine (9313) .....................
Tetrahydrocannabinols
(THC)
(7370).
Alphamethadol (9605) ..................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Cocaine (9041) .............................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oxycodone (9143) ........................
Meperidine (9230) ........................
Methadone (9250) ........................
Oxymorphone (9652) ...................
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
to manufacture controlled substance
derivatives. These derivatives will be
used in diagnostic products created
specifically for internal use only.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 10,
2006, Siegfried (USA), Inc., Industrial
Park Road, Pennsville, New Jersey
08070, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in Schedule
II:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
E:\FR\FM\02AUN1.SGM
02AUN1
Federal Register / Vol. 71, No. 148 / Wednesday, August 2, 2006 / Notices
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 2, 2006.
July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12475 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
Bureau of Justice Assistance; Agency
Information Collection Activities:
Extension of a Currently Approved
Collection; Comments Requested
Office of Justice Programs,
Department of Justice.
ACTION: 30 Day Notice of Information
Collection Under Review: Extension of
a currently approved collection.
wwhite on PROD1PC61 with NOTICES
AGENCY:
Bureau of Justice Assistance
Application Form: Southwest Border
Prosecution Initiative [OMB Number
1121–0270].
The Department of Justice (DOJ),
Office of Justice Programs (OJP) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed collection information is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register [Volume 71, Number 104,
pages 30962–30963 on May 31, 2006,]
allowing for a 60 day comment period.
The purpose of this notice is to allow for
an additional 30 days for public
comment until September 1, 2006. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
VerDate Aug<31>2005
16:40 Aug 01, 2006
Jkt 208001
response time, should be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention: Department of Justice
Desk Officer, Washington, DC 20530.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–7285. Comments may also be
submitted to the M. Pressley, Bureau of
Justice Assistance, Office of Justice
Programs, U.S. Department of Justice,
810 7th Street, NW., Washington, DC
20531 via facsimile to (202) 514–1590.
Written comments and/or suggestions
from the public and affected agencies
concerning the proposed collection of
information should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of this information:
(1) Type of information collection:
Extension of previously approved
collection.
(2) The title of the form/collection:
Bureau of Justice Assistance
Application Form for the Southwest
Border Prosecution Initiative.
(3) The agency form number, if any
and the applicable component of the
Department sponsoring the collection:
None.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State, Local or Tribal
government.
Other: None.
Abstract: The Southwest Border
Prosecutor Initiative was enacted in FY
2002 to reimburse state, county, parish,
or municipal governments for the costs
associated with the prosecution of
criminal cases declined by local U.S.
Attorneys. Each year, hundreds of
criminal cases resulting from federal
arrests are referred to local prosecutors
to handle when the cases fall below
certain monetary, quantity, or severity
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
43815
thresholds. This places additional
burdens on local government resources
that are already stretched by the
demands of prosecuting violations of
local and state laws. This program
provides funds to eligible jurisdictions
in the four southwest border states,
using a uniform payment-per-case basis
for qualifying federally initiated and
declined-referred criminal cases that
were disposed of after October 1, 2001.
Up to 220 eligible jurisdictions may
apply. This includes county
governments and the four state
governments in Arizona, California,
New Mexico, and Texas.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that no
more than 220 respondents will apply.
Each application takes approximately 60
minutes to complete and is submitted 4
times per year (quarterly).
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total hour burden to
complete the applications is 880 hours
(880 applications (220 × 4 times a year)
× 60 minutes per application = 52,800/
60 minutes per hour = 880 burden
hours).
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Policy and
Planning Staff, Justice Management
Division, 601 D Street, NW., Suite 1600,
Washington, DC, 20530, or via phone at
202–514–4304.
Dated: July 28, 2006.
Lynn Bryant,
Department Clearance Officer, Justice
Management Division, PRA, United States
Department of Justice.
[FR Doc. E6–12454 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–18–P
NUCLEAR REGULATORY
COMMISSION
Agency Information Collection
Activities: Submission for the Office of
Management and Budget (OMB)
Review; Comment Request
Nuclear Regulatory
Commission (NRC).
ACTION: Notice of the OMB review of
information collection and solicitation
of public comment.
AGENCY:
SUMMARY: The NRC has recently
submitted to OMB for review the
following proposal for the collection of
information under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). The NRC hereby
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 71, Number 148 (Wednesday, August 2, 2006)]
[Notices]
[Pages 43814-43815]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12475]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 10, 2006, Siegfried
(USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the
[[Page 43815]]
issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than October 2, 2006.
July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12475 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P
